Abstract
Adjuvant chemotherapy is one of the latest and more promising modality of cancer treatment within the multidisciplinary approach to neoplasms. This paper illustrates the biological rationale as well as preliminary evaluation of its effectiveness for bladder carcinoma.
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Combined Modality Therapy
-
Humans
-
Preoperative Care
-
Urinary Bladder Neoplasms / drug therapy*
-
Urinary Bladder Neoplasms / mortality
-
Urinary Bladder Neoplasms / surgery